Harvard Business Review

MARCH 2, 2018

The healthcare industry has long relied on traditional, linear models of innovation – basic and applied research followed by development and commercialization. An alternative emerging at healthcare institutions worldwide is human-centered design and co-creation, a set of approaches that can accelerate and humanize healthcare innovation.

Health Care 10

Health Care Innovation Mayo Stage-Gate 10

Harvard Business Review

MAY 5, 2015

It includes Mary Parker Follett (1920s), Elton Mayo and Chester Barnard (1930s), Abraham Maslow (1940s), Douglas McGregor (1960s), Peter Drucker (1970s), Peters and Waterman (1980s), Katzenbach and Smith (1990s), and Gary Hamel (2000s). As a result, customers’ expectations are raised.

Bureaucracy 8

Bureaucracy Management Drucker Waterman 8

Harvard Business Review

JULY 6, 2016

But for Catalyst, the pharmaceutical company that purchased the North American rights to a slightly modified formulation of 3,4 DAP (Firdapse) in 2012, the drug represented a market opportunity to the tune of $300 million to $900 million annually ($60,000 to $100,000 or more per patient).

Price 14

Price Pharmaceuticals Company Health Care 14